NCT00812305View on ClinicalTrials.gov

Hepatic Impairment Study: Pharmacokinetics in Healthy and Hepatically Impaired Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
PainHepatic Impairment
Interventions
DRUG

SKY0402 300mg in healthy patients

SKY0402, single administration of 300 mg via local infiltrations (subcutaneous) in healthy patients

DRUG

SKY0402 300mg in hepatically impaired patients

SKY0402, single administration of 300 mg via local infiltrations (subcutaneous) in hepatically impaired patients

Trial Locations (1)

Unknown

MTZ Clinical Research, Warsaw

Sponsors
All Listed Sponsors
lead

Pacira Pharmaceuticals, Inc

INDUSTRY